| Pharmaceutical active ingredients: |
| Methyldopa |
| Available forms, composition and doses of Grospisk: |
| N / A |
| Grospisk medical category: |
| Human:AntihypertensivesCentral alpha-agonists |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| C02AB - MethyldopaC02AB02 - Methyldopa (racemic) |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Unidentified Pharmaceutical Company |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Grizeofulvin | Griseofulvin | Unidentified Pharmaceutical Company |
| Groco | Linseed Oil | Unidentified Pharmaceutical Company |
| Grocolene | Glycerol | Unidentified Pharmaceutical Company |
| Grofollon | Follicle Stimulating Hormone | Unidentified Pharmaceutical Company |
| Grosafe | Carbon Black | Unidentified Pharmaceutical Company |
| Grysio | Griseofulvin | Unidentified Pharmaceutical Company |
| G-Strophanthin | Ouabain | Unidentified Pharmaceutical Company |
| G-Strophicor | Ouabain | Unidentified Pharmaceutical Company |
| Guaiamar | Guaifenesin | Unidentified Pharmaceutical Company |
| Guaianesin | Guaifenesin | Unidentified Pharmaceutical Company |